These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1210 related articles for article (PubMed ID: 3766867)

  • 1. Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications.
    Esclamado RM; Gown AM; Vogel AM
    Am J Surg; 1986 Oct; 152(4):376-85. PubMed ID: 3766867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
    Saxton RE; Mann BD; Morton DL; Burk MW
    Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors.
    Steuhl KP; Rohrbach JM; Knorr M; Thiel HJ
    Ophthalmology; 1993 Feb; 100(2):208-15. PubMed ID: 8437829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in cell binding patterns of two monoclonal antibodies recognizing distinct epitopes on a human melanoma-associated oncofetal antigen.
    Liao SK; Khosravi MJ; Brown JP; Kwong PC
    Mol Immunol; 1987 Jan; 24(1):1-9. PubMed ID: 2441244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cell-surface human melanoma-associated antigens identified by rabbit and murine antibodies.
    Bystryn JC; Jacobsen JS; Liu P; Heaney-Kieras J
    Hybridoma; 1982; 1(4):465-72. PubMed ID: 6208141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel neuroglandular antigen (NGA) expressed on abnormal human melanocytes.
    Sikora LK; Pinto A; Demetrick DJ; Dixon WT; Urbanski SJ; Temple W; Jerry LM
    Int J Cancer; 1987 Feb; 39(2):138-45. PubMed ID: 3804488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens.
    Kantor RR; Ng AK; Giacomini P; Ferrone S
    Hybridoma; 1982; 1(4):473-82. PubMed ID: 6208142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens.
    Harper JR; Bumol TF; Reisfeld RA
    Hybridoma; 1982; 1(4):423-32. PubMed ID: 6208137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and isolation of melanoma-associated antigens with monoclonal antibodies.
    Ross AH; Mitchell KF; Steplewski Z; Koprowski H
    Hybridoma; 1982; 1(4):413-21. PubMed ID: 6765324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections.
    Imam A; Mitchell MS; Modlin RL; Taylor CR; Kempf RA; Kan-Mitchell J
    J Invest Dermatol; 1986 Feb; 86(2):145-8. PubMed ID: 3528308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
    Jungbluth AA; Busam KJ; Gerald WL; Stockert E; Coplan KA; Iversen K; MacGregor DP; Old LJ; Chen YT
    Am J Surg Pathol; 1998 May; 22(5):595-602. PubMed ID: 9591730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a secreted Mr 95,000 glycoprotein in human melanocytes and melanomas by a melanocyte specific monoclonal antibody.
    Vogel AM; Esclamado RM
    Cancer Res; 1988 Mar; 48(5):1286-94. PubMed ID: 3342407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
    Orchard GE
    Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Workshop on monoclonal antibodies to human melanoma-associated antigens: findings of the Seattle group.
    Hellström I; Brown JP; Hellström KE
    Hybridoma; 1982; 1(4):399-402. PubMed ID: 6208136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
    Blessing K; Sanders DS; Grant JJ
    Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
    Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
    Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ analysis of antigens on malignant and benign cells of the melanocyte lineage. Differential expression of two surface molecules, gp75 and p89.
    Holzmann B; Johnson JP; Kaudewitz P; Riethmüller G
    J Exp Med; 1985 Feb; 161(2):366-77. PubMed ID: 3973533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of hybridoma-exchange antibodies.
    Lloyd KO; Albino A; Houghton A
    Hybridoma; 1982; 1(4):461-3. PubMed ID: 6208140
    [No Abstract]   [Full Text] [Related]  

  • 19. Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1.
    Kawakami Y; Battles JK; Kobayashi T; Ennis W; Wang X; Tupesis JP; Marincola FM; Robbins PF; Hearing VJ; Gonda MA; Rosenberg SA
    J Immunol Methods; 1997 Mar; 202(1):13-25. PubMed ID: 9075767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
    Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
    Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.